Stay updated with breaking news from Analytical Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revvity (NYSE:RVTY – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Revvity and Bruker’s net margins, return on […]
Revvity (NYSE:RVTY – Get Rating) is one of 69 publicly-traded companies in the “Diagnostics & Research” industry, but how does it weigh in compared to its competitors? We will compare Revvity to similar businesses based on the strength of its risk, earnings, dividends, analyst recommendations, valuation, profitability and institutional ownership. Volatility and Risk Revvity has […]
Revvity (NYSE:RVTY – Get Rating) is one of 70 public companies in the “Diagnostics & Research” industry, but how does it weigh in compared to its peers? We will compare Revvity to related businesses based on the strength of its dividends, profitability, risk, earnings, institutional ownership, valuation and analyst recommendations. Volatility and Risk Revvity has […]
Revvity (NYSE:RVTY – Get Rating) is one of 44 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Revvity to related companies based on the strength of its risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Risk & Volatility Revvity has a beta of […]
Revvity (NYSE:RVTY – Get Rating) and Precipio (NASDAQ:PRPO – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Profitability This table compares Revvity and Precipio’s net margins, return on equity […]